Merck & Co. has grown revenue 4.5% a year over three years and 8.7% a year over five, with earnings per share compounding at 1.1%. Revenue growth, 3-year annual rate: +4.5% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +8.7%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +1.1%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 19, FY2007 to FY2025, as filed.

MRKMerck & Co.

HealthcareUSD

$153.16

$75.8352 weeks$156.44

Is it growing?

Is MRK growing?

Merck & Co. has grown revenue 4.5% a year over three years and 8.7% a year over five, with earnings per share compounding at 1.1%.

+4.5%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +8.7%
Revenue growth, 5-year rate · +4.5% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +1.1%
Earnings per share, 3-year rate · revenue +4.5% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed